Effects of interactions between drugs on the renal excretion of trientine in rats - Acetazolamide and furosemide increase trientine excretion

Pharmaceutical Research

Volumn 16, Issue 12, 1999, Pages 1888-1892

  Kobayashi, Michiya ^a   Fujisaki, Hiroko ^a   Sugawara, Mitsuru ^a   Iseki, Ken ^a   Miyazaki, Katsumi ^a  

^a HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acetazolamide; Diuretics; Drug interaction; Furosemide; Renal excretion; Trientine

Indexed keywords

ACETAZOLAMIDE; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIPORTER; CIMETIDINE; COPPER SULFATE; DIURETIC AGENT; FUROSEMIDE; SODIUM ION; SPERMINE; TOBRAMYCIN; TRICHLORMETHIAZIDE; TRIENTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRUSH BORDER VESICLE; CONTROLLED STUDY; DRUG URINE LEVEL; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EPITHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

EID: 0033451244     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018963712232     Document Type: Article

References (17)

1. I. H. Scheinberg and I. Sternlieb. Wilson's Disease, Saunders, Philadelphia, 1984.
2. C. D. Marsden. Wilson's disease. Quart. J. Med. 248:959-966 (1987).
3. J. M. Walshe. Treatment of Wilson's disease with trientine (triethylenetetramine) dihydrochloride. Lancet. I:643-647 (1982).
4. +/organic cation transporter. J. Pharm. Pharmacol. 49:426-429 (1997).
5. +/spermine antiporter in the rat renal brush-border membrane. J. Pharm. Pharmacol. 51:279-284 (1999).
6. J. Biber, B. Stieger, H. Hasse, and H. Murer. A high yield preparation for rat kidney brush-border membranes. Different behavior of lysosomal markers. Biochim. Biophys. Acta. 647:169-176 (1981).
7. K. Miyazaki, S. Kishino, M. Kobayashi, S. Arashima, S. Matsumoto, and T. Arita. Determination of triethylenetetramine in plasma of patients by high-performance liquid chromatography. Chem. Pharm. Bull. 38:1035-1038 (1990).
8. R. Tanabe, M. Kobayashi, M. Sugawara, K. Iseki, and K. Miyazaki. Uptake mechanism of trientine by rat intestinal brush-border membrane vesicles. J. Pharm. Pharmacol. 48:517-521 (1996).
9. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol regent. J. Biol. Chem. 193:265-275 (1951).
10. E. K. Jackson. Diuretics. In J. G. Hardman, A. Goodman Gilman, and L. E. Limbird (eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics (9th ed.), McGraw-Hill, New York, 1996, pp. 685-713.
11. M. Takano, K. Inui, T. Okano, and R. Hori. Cimetidine transport in rat renal brush-border and basolateral membrane vesicles. Life Sci. 37: 1579-1585 (1985).
12. D. H. Russell, C. C. Levy, S. C. Schimpff, and I. A. Hawk. Urinary polyamines in cancer patients. Cancer Res. 31:1555-1558 (1971).
13. T. P. Waalkes, C. W. Gehrke, D. C. Tormey, R. W. Zumwalt, J. N. Hueser, K. C. Kuo, D. B. Lakings, D. L. Ahmann, and C. G. Moertel. Urinary excretion of polyamines by patients with advanced malignancy. Cancer Chemother. Reports-Part 1. 59:1103-1116 (1975).
14. C. Loser, U. R. Folsch, C. Paprotny, and W. Creutzfeldt. Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer. Cancer 65:958-966 (1990).
15. S. Silbernagl, K. Völker, H. J. Lang, and W. H. Dantzler. Taurine reabsorption by a carrier interacting with furosemide in short and long Henle's loops of rat nephrons. Am. J. Physiol. 272:F205-F213 (1997).
16. F. G. Knox, F. S. Wright, S. S. Howards, and R. W. Berliner. Effect of furosemide on sodium reabsorption by proximal tubule on the dog. Am. J. Physiol. 217:192-198 (1969).
17. B. M. Brenner, R. I. Keimowits, F. S. Wright, and R. W. Berliner. An inhibitory effect of furosemide on sodium reabsorption by the proximal tubule of the rat nephron. J. Clin. Invest. 48:290-300 (1969).